BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HJB647 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HJB647\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07465653-563@assetmemo.bio
DTSTAMP:20261121T005829Z
DTSTART;VALUE=DATE:20261208
DTEND;VALUE=DATE:20261209
SUMMARY:HJB647: Phase 1 readout est. (NCT07465653)
DESCRIPTION:HJB647\, phase 1\, Heart Failure.\nStudy: A Safety and Tolerabi
 lity Study of HJB647 in Heart Failure Participants With Reduced Ejection F
 raction\nEstimated primary completion: 8 December 2026. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/hjb647#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT07465653
URL:https://assetmemo.bio/drug/hjb647#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07644364-563@assetmemo.bio
DTSTAMP:20261121T005829Z
DTSTART;VALUE=DATE:20261225
DTEND;VALUE=DATE:20261226
SUMMARY:HJB647: Phase 1 readout est. (NCT07644364)
DESCRIPTION:HJB647\, phase 1\, Hypertension.\nStudy: HJB647 Phase 1b Study 
 in Japanese Healthy Participants With Elevated Blood Pressure and Patients
  With Hypertension\nEstimated primary completion: 25 December 2026. This i
 s a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it ca
 n move.\nDrug page: https://assetmemo.bio/drug/hjb647#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07644364
URL:https://assetmemo.bio/drug/hjb647#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07940647-563@assetmemo.bio
DTSTAMP:20261121T005829Z
DTSTART;VALUE=DATE:20271105
DTEND;VALUE=DATE:20271106
SUMMARY:HJB647: Phase 1 readout est. (NCT07940647)
DESCRIPTION:HJB647\, phase 1\, Hypertension.\nStudy: A Safety and Tolerabil
 ity Study of HJB647 in Adult Participants With Uncontrolled Hypertension\n
 Estimated primary completion: 5 November 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/hjb647#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07940647
URL:https://assetmemo.bio/drug/hjb647#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
